Document Detail

Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan.
MedLine Citation:
PMID:  23387475     Owner:  NLM     Status:  Publisher    
Objective To examine the efficacy, acceptability and feasibility of early medical abortion, with the option of home administration of misoprostol, in Uzbekistan. Methods A total of 450 women were enrolled at national, municipal and private facilities in Tashkent, Uzbekistan. Women who presented for termination of pregnancy with gestations up to 63 days were recruited to participate in the study. All eligible pregnant women who consented to participate swallowed a 200 mg mifepristone pill in the clinic and were given the option of taking 400 μg misoprostol sublingually either at the clinic or at home 24-48 hours after mifepristone administration. Abortion status was determined two weeks later. Results Almost all women (99.5%) chose home administration of misoprostol. The sublingual route of misoprostol administration was acceptable or very acceptable to 89% of participants. Ninety-five percent of women had complete abortions after mifepristone and misoprostol. Almost all participants preferred a medical abortion to surgery for a future procedure (95%). Conclusions Mifepristone medical abortion with home administration of misoprostol is an acceptable and feasible option for women in Uzbekistan. The method worked well at all three facility types.
Sheila Raghavan; Tamar Tsereteli; Asamidin Kamilov; Dilfuza Kurbanbekova; Dilmurod Yusupov; Feruza Kasimova; Dilbar Jymagylova; Beverly Winikoff
Related Documents :
23335585 - Periodontal conditions during the pregnancy associated with periodontal pathogens.
24393725 - Consumer perspectives on a pericoital contraceptive pill in india and uganda.
22940525 - Nepa, epa and risk assessment: has epa lost its way?
24604625 - Revisiting retrospective reporting of first-birth intendedness.
24488175 - Association of multiple biomarkers and classical risk factors with early carotid athero...
23429755 - Dietary isoflavone intake, urinary isoflavone level, and their relationship with metabo...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-7
Journal Detail:
Title:  The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception     Volume:  -     ISSN:  1473-0782     ISO Abbreviation:  Eur J Contracept Reprod Health Care     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9712127     Medline TA:  Eur J Contracept Reprod Health Care     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
* Gynuity Health Projects , New York , USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Joint (Mis-)Representations: A Reply to Welsh et al. (2013).
Next Document:  Delta-like 1 Homologue (DLK1) is a Hypothalamus-Enriched Protein that is Present in Orexin-, but not...